Engels

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons Month 3 CENTRAL LABORATORY BLOOD NCT00079911

1 Formulieren  
Study administration
Beschrijving

Study administration

Subject Identifier
Beschrijving

Subject Identifier

Datatype

integer

Alias
UMLS CUI [1]
C2348585
Visit Date
Beschrijving

Visit Date

Datatype

date

Maateenheden
  • DD/MMM/YY
Alias
UMLS CUI [1]
C1320303
DD/MMM/YY
CENTRAL LABORATORY BLOOD
Beschrijving

CENTRAL LABORATORY BLOOD

Date sample taken
Beschrijving

Date sample taken

Datatype

date

Alias
UMLS CUI [1]
C1302413
INVESTIGATIONAL PRODUCT CONTAINER NUMBER
Beschrijving

INVESTIGATIONAL PRODUCT CONTAINER NUMBER

Record the identifying number from the investigational product container dispensed at this visit.
Beschrijving

identifying number

Datatype

integer

Alias
UMLS CUI [1,1]
C2609208
PREGNANCY TEST PROMPT
Beschrijving

PREGNANCY TEST PROMPT

HIV RNA PROMPT
Beschrijving

HIV RNA PROMPT

HIV-ASSOCIATED CONDITIONS
Beschrijving

HIV-ASSOCIATED CONDITIONS

CONCOMITANT MEDICATIONS
Beschrijving

CONCOMITANT MEDICATIONS

ADVERSE EVENTS
Beschrijving

ADVERSE EVENTS

Terug naar het begin van de pagina

Similar models

GSK Valaciclovir for the Suppression and Episodic Treatment of Genital HSV Infection in HIV-Infected Persons Month 3 CENTRAL LABORATORY BLOOD NCT00079911

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Study administration
Subject Identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Item Group
CENTRAL LABORATORY BLOOD
Date sample taken
Item
Date sample taken
date
C1302413 (UMLS CUI [1])
Item Group
INVESTIGATIONAL PRODUCT CONTAINER NUMBER
identifying number
Item
Record the identifying number from the investigational product container dispensed at this visit.
integer
C2609208 (UMLS CUI [1,1])
Item Group
PREGNANCY TEST PROMPT
Item Group
HIV RNA PROMPT
Item Group
HIV-ASSOCIATED CONDITIONS
Item Group
CONCOMITANT MEDICATIONS
Item Group
ADVERSE EVENTS
Terug naar het begin van de pagina